Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine-Reference-Cited by-同舟云学术

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

Published:2013-07 Issue:7 Volume:23 Page:709-720
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Björkholm Carl,Jardemark Kent,Marcus Monica M.,Malmerfelt Anna,Nyberg Svante,Schilström Björn,Svensson Torgny H.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference53 articles.

1. Prefrontal dopamine d1 receptors and working memory in schizophrenia;Abi-Dargham;J. Neurosci.,2002

2. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics;Akbarian;J. Neurosci.,1996

3. Clozapine and haloperidol modulate N-methyl-d-aspartate- and non-N-methyl-d-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro;Arvanov;J. Pharmacol. Exp. Ther.,1997

4. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder;Beneyto;Neuropsychopharmacology,2008

5. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group;Borison;J. Clin. Psychopharmacol.,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quetiapine improves sensorimotor gating deficit in a sleep deprivation-induced rat model;Sleep and Biological Rhythms;2023-12-14

2. Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism;European Neuropsychopharmacology;2022-09

3. The Pharmacogenetics of Treatment with Quetiapine;Future Pharmacology;2022-07-24

4. Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia;Schizophrenia Bulletin;2019-01-22

5. Elevated allostatic load early in the course of schizophrenia;Translational Psychiatry;2018-11-12